support@custommarketinsights.com+1 737 734 2707
  1. Home
  2. Press releases
  3. Global MRI Contrast Agents Market Size Likely to Grow at a C…
Press release · Healthcare

Global MRI Contrast Agents Market Size Likely to Grow at a CAGR of 8.87% By 2034

Veena JagtapSr. Research AnalystPublished Source Custom Market Insights

Key highlights

  • According to secondary analysis, the first quarter of FY25 was stable, with hospitals and diagnostics growing by 12-15 percent.
  • These markets are expected to rise due to strong margins and prospects.
  • Although government investment to contain the pandemic resulted in considerable increases in NHE, these expenditures fell dramatically in 2021, while medical goods and services usage rebounded.

The CMI Team's most recent market research predicts that from 2025 to 2034, the global MRI Contrast Agents Market will grow at a CAGR of 8.87%. In 2025, the market size is projected to reach a valuation of USD 2.7 Billion. By 2034, the valuation is anticipated to reach USD 5.85 Billion.

$2.7 BnMarket size, 2025
$5.85 BnForecast, 2034
8.87%CAGR, 2025-2034

MRI Contrast Agents Market Size 2025 to 2034

To learn more about this report - request a sample report PDF

MRI Contrast Agents Market: Growth Factors and Dynamics

A growing number of diagnostics centres and hospitals

The creation of additional diagnostic facilities and hospitals, particularly in developing countries, is boosting the availability of MRI scans, driving up demand for contrast agents. According to secondary analysis, the first quarter of FY25 was stable, with hospitals and diagnostics growing by 12-15 percent.

In FY24, the Indian hospital market was valued at ₹8.21 lakh crore, while the diagnostic labs market was valued at ₹1.2 lakh crore. These markets are expected to rise due to strong margins and prospects. Thus, the aforementioned statistics drive market expansion.

Rising healthcare expenditure

With growing healthcare spending, hospitals and diagnostic centres are more likely to use advanced imaging technology such as MRI, which drives the market growth. According to data published by the American Medical Association, healthcare spending in the US increased by 4.1% in 2022 to $4.5 trillion, translating to $13,493 per person.

This growth rate is comparable to the pre-pandemic rate (4.1% in 2019). Although government investment to contain the pandemic resulted in considerable increases in NHE, these expenditures fell dramatically in 2021, while medical goods and services usage rebounded. By 2025, top-level health spending trends will be more similar to those seen before the pandemic.

Presence of alternatives

Ultrasound and Positron Emission Tomography (PET) scans are two types of contrast-free imaging methods available in the market. These MRI imaging technologies are growing to provide detailed pictures without the need for contrast agents. This technology might reduce dependence on contrast-enhanced MRI scans, posing a threat to the MRI contrast agent industry.

Report Scope

Feature of the Report Details
Market Size in 2025 USD 2.7 Billion
Projected Market Size in 2034 USD 5.85 Billion
Market Size in 2024 USD 2.5 Billion
CAGR Growth Rate 8.87% CAGR
Base Year 2024
Forecast Period 2025-2034
Key Segment By Product, Type, Application, End-use and Region
Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying Options Request tailored purchasing options to fulfil your research requirements.

MRI Contrast Agents Market: New Launches and Acquisitions

  • In June 2023, Bayer launched the Phase III clinical development program QUANTI, which will assess the efficacy and safety of gadoquatrane, a next-generation extracellular, macrocyclic, gadolinium-based contrast agent (GBCA) for use in magnetic resonance imaging (MRI).

List of the prominent players in the MRI Contrast Agents Market:

  • Bayer AG
  • GE Healthcare
  • Bracco
  • Guerbet
  • Vitalquan LLC
  • Miltenyi Biotec B.V. & Co. Kg
  • Mallinckrodt Inc.
  • JB Pharma
  • Beijing Beilu Pharmaceutical Co. Ltd.
  • DAIICHI SANKYO COMPANY LIMITED
  • Trivitron Healthcare
  • BioPAL Inc.
  • Bruker
  • Others

The MRI Contrast Agents Market is segmented as follows:

By Product

  • Paramagnetic Agents
  • Superparamagnetic Agents

By Type

  • Clinical
  • Preclinical

By Application

  • Gastrointestinal
  • Intravenous
  • Hepatobiliary
  • Neurological Imaging
  • Others

By End-use

  • Hospitals
  • Imaging Centers

Regional Coverage:

North America

  • U.S.
  • Canada
  • Mexico
  • Rest of North America

Europe

  • Germany
  • France
  • U.K.
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • New Zealand
  • Australia
  • South Korea
  • Taiwan
  • Rest of Asia Pacific

The Middle East & Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa

Latin America

  • Brazil
  • Argentina
  • Rest of Latin America

Rate this press release

Share this press release

About the author

Veena Jagtap

Sr. Research Analyst

Research Analyst at Custom Market Insights, specializing in market research, competitive analysis, industry trends, and growth opportunities. Focused on transforming complex data into actionable insights that drive strategic decision-making and business growth.

View profile and reports

About Custom Market Insights

Custom Market Insights is a market research and advisory company. It publishes syndicated reports across 18+ industries and delivers custom research, feasibility studies and market entry strategy for companies, investors and consultancies.

Sales and media enquiriessupport@custommarketinsights.com
+1 737 734 2707

###

Free sample

Get the sample report

Global MRI Contrast Agents Market: sample pages and table of contents by email.

Security codeCode didn’t load.

We use these details only to answer this request. Privacy policy